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In 50 to 60 percent 01" patients with systemic lupus erythematosus (SLE) , a band of im-
munoglobu lins accumulates beneath the ep idermis of visibly normal skin . This h ighly spe-
cifi c find ing has been used as a di agnostic test (Lupus Band Test) for SLE. S imilar immuno-
globulin depos its a re found in an inbred stra in of New Zea land mice which spontaneously 
develop an autoimmune di sease with many features of SLE. Subepiderma l immunoglobu lin 
depos its a re found most frequently in SLE patients wi th proli ferat ive glomerulonephri t is, 
hypocomplemente mia, and serum ant ibodies to native DNA (anti-nDNA), When anti -nDNA 
levels a re suppressed by cyclophospha mide, these deposits disappea r. 
The subep iderma l accumulation of immunoglobulin in SLE patients and in the mouse 
model 'appa rently depends on the presence of antibody to native DNA. It is proposed that 
serum ant i-nDNA precipitates with nDNA which is released loca lly from epidermal nuclear 
breakdown . 
Systemi c lupus erythematosus (SLE) is char-
acteri zed by the presence of se rum ant ibodies to 
numerous autoant igens, particularl y nuclear 
constituents. The study of the specificity of these 
ant ibod ies in relation to the diagnosis, patho-
genesis, and clinica l ex pression of thi s di sease 
began with the discovery that antibody to nu-
cleoprote in produced the LE-ce ll phenomenon 
(1], whi ch was considered diagnostic for SLE. It 
soon became apparent, however, that LE ce ll s 
were not pathognomoni c for SLE, so the sea rch 
for d isease-specific autoan tibodies continued . 
With the recent deve lopment of relatively rap id , 
. simple, and reprodu cible techniques for detect-
ing and quantifyi ng ant ibod ies to double-stranded 
or native deoxyribonucleic ac id (nDNA) [2,3 ], 
an t i-nDN A has been shown to be highl y specifi c 
for idiopathi c SLE [4- 7). Serum ant i-nDNA is not 
usuall y found in lupus- like syndromes assoc iated 
with drugs and chronic li ve r disease in which LE 
cell s are often present [8,9 ). In addition, anti -
nD NA is closely 'correla ted with hypocomple-
mentem ia, disease activi ty, and particula rly with 
active progressive rena l di sease [6]. For these 
reasons, it is a useful guide for selecting ap pro-
priate treatment and for following the therapeu-
t ic response. 
The F I hybrid of New Zealand black and white 
mice (N ZB/W) spontaneously deve lops a di sease 
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wh ich is remarkably similar to human SLE [10] . 
These animals a lso have antibodies to nDNA [11, 
12J. Anti-nDNA can be detected in the sera of 
som e of the female hybrids at 4 to 6 months; by 6 
to 8 months, it is invariab ly present, and by 10 
months most animals die with an immune com-
plex-mediated nephriti s [13]. Immunofluorescent 
studies have shown tha t host immunoglobulin (Ig) 
and complement (C '3) accumulate in the glomeruli 
during the course of the disease in both mice [13J 
and man [14,15) . The 19 recovered from these 
tissues has ant inuclear [13) and anti-DNA [16) 
activity. Antibodies to native DNA cannot be in-
duced in experim ental animals; hence only those 
patients a nd animals which spontaneously de-
velop these remarkably similar autoimmune dis-
eases produce antibodies to native DNA. 
These findings have given considerable insight 
into the mechanism involved in the rena l lesion ill 
SLE. Little is known, however, about the patho-
logic signifi cance or antibody specificity of the 
Ig deposited at other sites in this multisystem 
di sorder. 
In 1963, Burnham, Neble tt, and Fine [17] de· 
scr ibed a band of locali zed Ig at the dermal- epi-
derma l junction of skir. lesions in both systemic 
and discoid LE. In 1964, Cormane (18J demon· 
strated that ce rta in SLE patients had a band of 19 
at the derma l- epiderma l junction of visib ly normal 
skin. Since then severa l studies [19- 21 J have es· 
tablished the diagnostic specificity for SLE of sub· I 
epIdermal Ig depos its in normal skin. Some stud· 
ies [22- 24J have suggested that this findin g is also l of prognostic significa nce. Antinuclear an t ibody 
activity has been demonstrated in the Ig deposi ted 
in SLE skin [25,26); however, the exact anti· 
body spec ificity rema ins a mystery. 
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The purpose of this article is to review the find -
ings from our laboratory of studies that have fo-
cused on the s ignificance of cutaneous immuno-
IY lobu lin deposits in patients with lupus 
:rythematosus [27-29,t l and New Zea la nd (NZ) 
mice [30,t ). On the basis of this information, the 
curren t con cept of the pathologic a nd c!inica l s i ~­
nificance of cu ta neous llnmunoglobulll1 deposI-
tion in these cond itions will be di scussed. Evi -
dence that the accum ulation of subepiderma l 
Ig may depend on the presence of serum antibody 
to native DNA will be presented . 
HUMAN STUDIES 
Patients and controls. Over the past 3 years , 317 
skin biopsy spec imens from 223 patients and 10 
normal s ubjects have been exam ined by a standard 
direct fluorescent a ntibody (FA) technique de-
scribed elsewhere [27 ). Table I lists the patients 
according to di agnosis and gives t he results of FA 
staining. S ubepiderm a l Ig deposits were detected 
in t he v is ibly normal , light-protected skin of 47 
(53%) of 87 SLE patients. None of the biopsy 
specimens from the normal subjects and only 4 
from a contro l group of related diseases had s imil ar 
Ig deposits . Two of the 4 had obv ious clinica l 
features of bullous pemphigoid , 1 had rheumatoid 
arthritis, and 1 had primary biliary cirrhos is with 
widespread li chen (and macular) amyloidosis. 
Subepidermallg staining in SLE. The frequ en -
cy- distribution of immunoglobulin classes identi-
fied in the subepidermal deposits is shown in 
Figure 1. Thirty-seven of the 47 SLE patients with 
s ubepidermal sta ining had IgG at the dermal- ep i-
dermal junction and a n equa l number had IgM. 
Complement (C'3) was identified in 26 patients; 
IgA was seen in on ly 8. IgM, with or without C '3, 
occurred alone in 10 patients. Therefore, a s ignifi-
cant number of patients would have been omitted 
fro m the b and-pos itive group had anti-IgM not 
been utilized. The most frequent combination was 
IgG and IgM. IgA was found only occas ionally a nd 
always with IgG. 
Vascular staining in SLE. Eleven SLE patien ts 
had staining of the walls of blood vessels in t he 
upper derm is (Fig. 2). Ten of these also had 
subepidermal Ig deposits . One patient had vascu-
lar staining for C'3 only. IgM was found in 8 of 10 
and it was usually unaccompanied by anot her Ig. 
Cryoglobulins were detected in 1 patient with a 
persistently low complement (C 'H50) and a recur= 
rent purpuric eruption on the lower extremities. 
This patient had deposits of IgG, IgA, and IgM in 
skin vessels. A second patient had an episode of 
cutaneous vasculiti s severa l weeks after vascu la r 
staining had been detected in norma l skin . None of 
t he other patients with vascular staining had 
cryoglobulinem ia or clinica l evidence of vasculi t is . 
t Gilliam IN, Ziff M: (1n preparation) 
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TABLE 1. Fluorescent antibody (FA) staining of clinically 
normal skill of patients with systemic lupu.s 
eryth emotosus and allied diseases. 
No. No. with Diagnosis subepi· tested dermal !K 
Systemic lupus erythematosus 87 47 
Disco id lupus erythematosus 27 0 
Drug- induced lu pus syndrome 7 0 
Rheumatoid arthritis 10 I 
Scleroderm a 12 0 
Dermato myositis 10 0 
Sjogren's synd rome 2 0 
Bullous pemphigoid 5 2" 
Hepatitis (Austra li a antigen 
positi ve) 8 0 
Glomerulonephri tis 
(poststreptococcal) 8 0 
Secondary syphili s 4 0 
Cryoglobulinemia (mixed type) 3 0 
Lupoid hepat itis 2 0 
Prim ary biliary cirrhosis 3 1 
Miscellaneous skin diseases 27 0 
Normal b 10 0 
" Linear sta ining of the epidermal base ment mem-
brane. 
II Skin specimens from 5 normal volunteers and from 5 
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Subepidermal Dl?Posits 
In 47 SLE Patients 
FIG. 1. Frequency- di stribution of immunoglobulin 
classes in the subepidermal immunoglobulin depOSIts III 
47 SLE patients. 
Epidermal nuclear staining in SLE an.d related 
disorders. When examined by the direct t1uores-
cen t antibody techriique , biopsy specimens from 12 
patients with SLE a nd 4 with atypical forms of 
polymyositis, DLE, rheumatoid arthrit is, and scle -
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o 5 10 
Vessel Wall Deposits 
11 Patients 
FIG. 2. Freq uency- d istri bution of imm unoglobu lin 
classes in the vesse l wa lls of 11 SLE patIents. 
roderm a had immunoglo bulin fixed to epiderm a l 
nucle i (Fig. 3) . In a ll cases, t he sta ining pattern 
was t hread y or speckl ed and IgG was t he only 
immunoglobulin prese n t. T his was a co ns isten t 
finding w hen each biopsy specimen was res t a ined 
a nd when s ubsequent biopsy spec imens from t hese 
pat ien ts were s t a ined. S ince seve ra l pat i.en ts. had 
t h e clinical features of t he ml xed con nectlve tissue 
d isease syndrom e descri bed by S ha rp et al [31) a nd 
s ince a ll of t hem had hi gh se rum t ite rs of a 
speckl ed staining a n t inuclear a n t ibody, t heir sera 
were tested for ant ibodies to a n ext racta ble nuclear 
antigen (ENA). An t i-E N A was measured by t he 
he magglu t in at.ion method of S h arp et a l (7) . Th e 
sera from a ll 16 pa tients h ad hi gh t ite rs ( ~ 
1 :32,000) of a ntibod y to extrac ta ble nu clear an t i-
gen , bu t s ignifi can t a m oun ts of an t ibody to native 
D NA (an t i-nDN A) were found in only 3. An 
indirect flu orescent an t ibod y techniq ue us ing en-
zy me-treated rat kidn ey s u bstr ate Ehowed that 
t hese 3 pat ien ts ha d an t ibodi es to a n RN ase- res ist-
a nt nuclear a n t igen .§ The loca lization of immuno-
glo bulin to ep iderm a l nucl e i has been p rev iously 
de monstrated by direct FA s t a inin g of skin biop-
s ies from norm a l S LE skin [32,33 ], bu t its s ignifi -
cance has not been known. In our ex perience, when 
t he nuclea r staining pattern is t he t hready ty pe, 
t his findin g has been assoc iated in every case wi t h 
hi gh t ite rs of a n t i-ENA. Direct FA sta ining of skin 
b iops ies from t he vis ibly norm a l skin of 2 patients 
resul ted in epiderm al nucleo lar sta in in g (F ig. 4). 
Neit her o f t hese pat ients ha d serum a n t ibodies to 
EN A, bu t both had high t ite r ANAs w it h nu cleolar 
pattern s. One pat ien t ha d R ayn a ud 's d isease, t he 
other ha d sc leroderm a wit h Rayna ud's pheno me-
non . 
This nuclear sta inin g p henom enon a ppears to be 
prod uced in v it ro [29 ). Hi gh co ncen t rat ions of 
eas ily diffus ible a n t inuclear a n t ibodi es in t he der -
mis p rob ably ga in access to ep ide rm a l nuclear 
an t ige ns at t he t ime the t issue is sectioned , a ir 
S Gillia m IN, miley J O, ZilTM: (Submi tted for publica· 
t ion) 
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dried , or prewashed . Ve ry like ly the process of 
freezing a nd th aw ing destroys m e mbrane integri ty 
and a llows free diffus ion of a nt ibod y in to t h e 
epiderm al ce ll s. 
The clinical sign ificance of subep idermal de-
posits in uninvo lved skin . C linical a nd laboratory 
pa ra mete rs 0 [' disease activi ty , rena l disease, a nd 
ren a l hi s tology have been studi ed in relat ion to t h e 
immunoflu orescen t fin d in gs in t he skin [27 ]. In 
this study a s ignifi can t correla tion betwee n hy po-
co mple mell te m ia, p ro life rat ive glome ru lonephri -
t is, a nd sub e piderm a l immunoglobulin was fo und. 
Over t he past 3 yea rs seq uenti a l skin bio psies a nd 
serologic studi es have been perform ed to establi sh 
the temporal relat ionship between ch a nges in 
se rum a nt ibody level a nd cu taneous i1uo rescen ce. 
An t inuclea r a n t ibod y, determined by the in -
direct FA techni q ue wi t h rat kidn ey s ubstrate, 
occurred as frequ ent ly in pati en ts wi t hou t subepi -
derm a l Ig (17/19) as in t hose with cu taneous Ig 
deposits (21/23) . H owever, t he periphera l staining 
pattern was foun d m ore often in t hose wi t h sube pi -
derm a l Ig d e pos its (T ab le II) . P eriph era l staining 
h as been cOJ'l'e lated wit h disease activ ity, ren a l 
d isease, a nd a n t i-nD NA [34 ]. 
Serum an t i-nD N A was measured in 42 pat ien ts 
by m ea ns of the Millipore fil te r method of G insberg 
a nd Ki eser [2 ]. Se ra for t hese determ i na t ions were 
obta ined at t he same t im e, wi t hin a n 8-week period 
befo re a nd a fter t he s kin biopsy. E leven of 12 
PIG. 3. T hready sta ining of epiderma l nu cle i in skin 
from a patien t wi th mixed connective t issue disease ( 
430). 
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FIG. 4. Nucleola r s ta ining in epidermal nuclei of skin 
from a patient with sc leroderma ( x 430) . 
TABLE JI. Antinuclear antibody tes t £n relation to 
subepidermal immunoglobulin (lIZ ) deposition ill 
otherwise Il ormal sh in 
Staining No. or 
No. wi t h % wit.h 
subepiderm al subepidermal patte rn patients Ig II( 
Hom ogenous 25 12 48 
Periphe r·a l 7 6 86 
Thready 6 4 67 
Negative 4 2 50 
patien ts (92%) with elevated levels of anti-nDNA 
before or at t he t ime of skin biopsy had subepider-
mal Ig in corresponding skin biopsy specimens 
(Table III). On the other ha nd, onl y 8 of30 patients 
or 27% of those with low or undectectable levels of 
anti-nDNA before or at t he t ime of skin biopsy had 
positive subepidermal s taining (p < 0.025). 
Total hemolytic complement 'leve ls (C 'H 50) 
were determined by t he method of Ne lson , Jenson , 
Gigli, and T amura (35 ). A highly significant (p < 
0.001 ) correl ation was fo und between depression of 
the serum complemen t levels a nd subep iderm a l 19 
(Tab. IV). 
T a ble V sum marizes t he re la tionship between 
the renal hi sto patholog ic findin gs and subepider-
mal 19 in t issue from 32 SLE patients. These were 
classified in two groups accord ing to the known 
correlation between renal histopathologic changes 
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in SLE and subseq uent progression and prognos is 
(36). In group I are t he patients wit h relat ively 
more severe a nd progressive form s of SLE renal 
di sease, i.e., prolife rat ive glomerul one phritis 
(PGN) a nd me mbranous glomerulonephritis 
(MembGN). Group II is composed of patients with 
mesangial glomerulitis (MesG) or with normal 
findings . MesG is a relatively mild focal les ion 
which is assoc iated with a good prognosis [37]. 
Thirteen of 14 (93%) with PGN and 3 of 5 (60%) 
with MembGN had subepidermal staining. Thus, 
in the group with more severe renal involvement, 
16 of 19 pa t ients , or 84%, had subepiderm al Ig 
deposi ts. However , only 3 of 13 (23%) group II 
patients had sta ining at the dermal- epidermal 
junction . 
The pathologic significance of subepidermal im -
munoglobulin. deposits in. SLE. Table VI lists t he 
different types of sk in involvement observed in 44 
TABLE I.IT. Antibody to native DNA in relation to 
subepidermal Ig deposition in normal skin 
No. of No. wi th % with Anti -nO NA subepidermal subep idermal patients Ig Ig 
Pos itive" 12 11 92 
Negat ive 30 8 27 
p < 0.025 
" Values of 2 }J g of DNA bound per ml of serum or 
greater cons idered pos itive . 
TABLE IV. Serum complement (C' H50) in relation to 
subepiderm.al Ig in norm.al skin 
No. pa tients No. with 
% with 
C'HSO" subepiderm al subepiderm al tested Ig Ig 
Low 22 20 91 
Norma l' 20 3 15 
" C' H50, total hemolytic complement. 
b Norm a l range, 60- 110 hemolytic units . 
TABLE V. Renal biopsy findings in relation to 
subepidermal [ g ill normal shin 
His tologic No. or No. with % with Group class ifi - patients subep iderm al sube piderm al 
ca ti onl l Ig Ig 
PGN 14 13 
I 84 
MembG 5 3 
MesG 9 3 
n 23 
Norma l 4 0 
P < 0.005 
" PGN, proliferat ive glomerulonephritis ; MembGN , 
membran ous g lomerul onephriti s; MesG, mesa ngia l 
glomerulitis; Norma l, no light microscopic abnorma li -
t ies. 
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SLE patients and the findings of FA staining of 
biopsies from uninvolved skin. The terms acute 
and chronic LE lesions indicate that the findings 
were clinically or histologica ll y diagnost ic of LE. 
These were considered to be characteristi c of the 
LE lesions that a lmost always have subepidermal Ig 
deposits (38]. However, only 2 of 12 patients (16%) 
with chronic destructive LE lesions had subepider-
mal Ig in normal skin. This figure is well below the 
expected 50 to 60% overail prevalence and sug-
gests that subepidermal Ig in normal skin plays a 
protective role during the development of chronic 
destructive discoid -type skin lesions. This inverse 
correlation between skin disease and subepidermal 
Ig was not observed in those with t he acute LE 
lesions since 8 of 15 (53%) of these had 19 deposits 
in uninvolved sk in . On the other hand, there is 
nothing to suggest that subepidermal Ig deposits 
play a causative role in these acute lesions since 
the frequency of 19 deposits in the normal skin of 
these patients was identical with that found in the 
large unselected sample of SLE patients . 
The effect of immunosuppression on the subepi-
dermal Jg in normal skin. Table Vll shows the 
TABLE VI. Skin diseases in SLE in relation to 
subepidermal Ig in uninvolved skin 
No. with % with 
Clinica l No. of subepi - subepi -
classifi cation patients derm al derm al 
19 19 
Acute transient LE 15 8 53 
lesions 
Chronic destructive 12 2 16 
LE les ions 
Alopecia (diffuse) 9 5 56 
Cutaneous ulcers 2 0 0 
Dermal vasculitis 3 2 67 
U.rticaria 1 0 0 
Erythema nodosum 1 0 0 
Recurrent thrombo- 3 0 0 
phlebitis 
Vol. 65, No . 1 
TABLE VII. The effec t of treatment on subepidermal Ig 
deposits in normal shin 
No. with No. with 
subcpi - subepi - % with 
Treatment derm allg dertna! 19 subepi-
before after 4 derm allg months of treatment treatment 
Prednisone 17 13 76 
Cyclophosph amide 9 1 12 
and prednisone 
p < 0.05 
effect of treatment on cutaneous Ig deposits . 
Twenty-six patients with subepidermal Ig have 
had sequenti.al biopsies after taking prednisone 24 
mg per day (average) or a combination of 26 mg 
prednisone per day and cyclophosphamide (Cy-
toxan) 1.8 mg per kilo (average). All of the 
patients taking cyclophosphamide had biopsy-
proven proliferative or membranous glomerulone-
phritis . These patients a lso had prominently ele-
vated anti-nDNA levels before cyclophospham ide 
treatment. Of the 17 patients treated with predni-
sone alone, 13, or 76%, still had detectable subepi-
dermal Ig after 4 months of treatment whereas only 
1 of 9, or 12%, of those receiving cyclophosphamide 
and prednisone had positive subepidermal staining 
after the same treatment period. Serum anti-
nDNA dropped to undetectable levels in the first 
12 weeks of treatment and all patients who were 
anti-nDNA negative at 3 months had negative 
subepidermal staining 1 to 2 months later. 
ANIMAL STUDlES 
The results of serum an t inuclear ant ibody 
(ANA) and flu orescent antibody staining of animal 
tissues are given in Table VIII. Subepidermal 
staining was observed in 25 of the 75 animal 
s tudied . Ig was not detected in the skin of con trol 
CBA/J mice or in the skin of N ZB/W F I hybrids 
under 6 months of age. The location and appear-
ance of the staining in the mice was simil ar to that 
TABLE VIII. Prevalence of seru.m antinuclear antibody (ANA) , su.bepiderma l and glomerular immunoglobulin (Ig) in 
female NZB/NZW F, hybrid mice at different ages" 
Serum ANA SubepidermalIg Glomerul ar Ig 
Age 
(months) No. No. % No. No. % No. No. % 
tested positive positiv e tested positi ve pos itive tested pos it.ive posit.ive 
3 12 0 0 10 0 0 10 0 0 
4 12 2 17 10 0 0 
5 12 4 33 9 3 33 
6 12 6 50 11 1 9 
7 12 10 83 10 3 30 11 10 91 
8 10 9 90 10 5 50 
9 10 6 60 5 5 100 
10 
11 6 5 83 
12 5 5 100 
a Staining was read as positive if one of the Ig classes was detected. 
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FIG. 5. Sta ining of a subep iderm al ba nd of immuno-
globulin in a skin spec imen from a female (NZB x NZW) 
F , hybrid mouse ( x 150). 
seen in t he skin of hum an SLE patients (Fig. 5). Ig 
de pos it ion in t he skin was detected about 1 to 2 
m on t hs after t he appearance of ant inuclear ant i-
body in the se rum and Ig in the glomerulus (Fig. 6) . 
After t his initia l lag period, the percentage of 
anim a ls wi th skin and glomerular fluorescence rose 
in a pa ra llel manner with age. 
DISCUSS ION 
These studies have shown that the subepidermal 
band of immunoglobulin in apparent ly norm al 
SLE skin (the lupus band ) correlates with se rum 
antibody to native DNA (an t i-nDNA) and that the 
N ZB/W F I hybrid mice, which also have serum 
an t i-nDNA, have similar subepidermal Ig depos its. 
In addi t ion, by means of sequent ia l skin biopsies, 
the tempora l relationships between an tibody sup-
pression by cyclophosphamide and the subsequent 
disappearance of subepidermal Ig, on the one hand, 
and in creased an tibody production during periods 
of active di sease and accumulation of subepidermal 
Ig, on the other, have been observed. 
The evidence that the lupus band is composed of 
nD N A: ant i-nDNA complexes has been strength-
ened by the above findings. The specificity of t he 
lupus band for human SLE [19-21), its association 
with disease activity [21], hypocomplementemi a 
[21,22,27], renal disease [22,24,27], and the pres-
ence of an t inuclea r activity in skin eluates [25,26 ) 
all suggest a close associa tion between subepider-
mal Ig and anti-nDNA. The findin gs fur ther 
strengthen this suggestion by correlating the sub-
epidermal Ig depos its with serum ant i-nDNA and 
by showing tha t subepidermal Ig accumulates in 
aging NZB/W F I mice. 
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T he serum concentration of ant ibody to native 
DNA and its duration in the circulation appear to 
be im portant determi nants for t he accumulation of 
Ig at the dermal- epiderm al junction. During the 
process of norm al keratinization, epiderm al nuclei 
are broken down and nuclear materi al including 
nDNA may be liberated. Recently Hun ter, Dilley , 
and Holman (39 ) have reported that native DNA 
can be ident ified in norm al human plasma speci-
mens. One implication of this finding is that 
significant quant it ies of nD NA must be cont inu -
a lly liberated from endogenous sources. If t he 
epidermis is a source of this endogenous nDNA, 
then the subepidermal collection of immunoglobu-
lin would be expected in those condi tions which 
characteristica lly have serum ant ibody to nD NA, 
i.e., systemic lupus erythematosus and the auto im-
mune disease of NZB/W F, mice. Indeed , Nata li 
and Tan (40 ) have shown that a subepidermal 
band of immunoglobulin accumulates at sites of 
UV irradiat ion in mice which have serum anti body 
to UV -a ltered DNA. Their experiments demon-
strate that under these condi tions epiderm al nu -
clear ant igens are released and prec ipitate at the 
dermal- epidermal junction when the correspond -
ing serum ant ibody is present. In SLE and NZB/ W 
F I mice, subepidermal Ig accumulation does not 
depend on UV irradia tion, and anti body to UV-
altered DN A is not a characteristic feature of these 
diseases. However a similar mechanism involving a 
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FIG. 6. Preva lence of antinuclear antibody (- - -t;,.- - - ), 
glomerular fluorescence (--e--), and subep idermal 






P IG . 7. Proposed mechani sm of subepiderm a l 19 accu-
mulation. A: Liberation of" ep iderm al nu clea r materi a l 
during the process of" norm al keratini zation may resul t in 
back-diffusion of nONA ( + ) in to the dermi s. Und er 
norm al circumstances this nD NA would pass through the 
subepiderm al zone and be removed by t he blood and 
lymp hatic vesse ls. B: When anti-nON A ( Z ) is present, 
t he epidermal nD NA and anti -nDNA prec ipitate in t he 
subepide rm a l zone. Therefore, the form ation of t.his 
subepiderm a l prec ipitate of nO NA ; anti -nDNA is in -
flu enced by both local and systemi c factors. 
nDN A: an t i-nDNA m ay be involved as illustrated 
in Figure 7. In a ddition to se rum a n t ibod y con cen -
t r a tion , t he local conce nt ration or rate of re lease of 
a n tige n must play a n impor ta n t role in d etermin -
in g wh eth er d etecta ble a m ounts of subepiderm a l 
a n t igen- a n t ibody co mplexes a ppear. The ra t e of 
. nD N A re lease m ay d epend on m a ny fac tors su ch as 
epiderm al p ro liferat ion , lysoso m a l en zym e release, 
D N A d a m age, ce llul a r injury, and diffusabili ty 
[41). This m ay pa rt ia lly expla in the differen ce 
between t he in cide nce of th e band in light-exposed 
versus I igh t- protecied s ites a nd betwee n les iona l 
a nd nonles iona l s kin . 
The exact rela tionship between im mune com-
plex d e pos it ion in SLE skin and t he d eve lopmen t 
of infl a mm atory skin les ions is not known. Indeed , 
pe rs isten t d es tructive LE skin lesions are ra re ly 
observed in pa ti en ts wi t h prolife ra tive glom erulo -
nephritis, s ignifica nt e levations of a nti-nD N A, or 
subep iderm a l Ig d eposits in uninvolved skin [27,'\1). 
The absen ce of his tolog ic or immunopathologic 
d ata to im plicate a n t igen - antibody co mplex-
m edi ated injury a nd th e presence of pa tholog ic 
features which suggest a ce ll -m edi ated immune 
response have led to t he conclus ion that t hese s kin 
les ions a re a m a nifes tat ion of T cell -m ediated 
injury. The pers istent nature of these les ions su g-
gests cont inua l libe ra tion or sequestra tion of an t i-
gen , perh a ps epide rm a l nD N A, resul t in g in t he 
act ivat ion of specifi cally sens it ized T cells. The in-
verse re lationship between chronic scarring skin 
lesion s a nd serum a nti-nDN A could be du e to in -
te rfe ren ce of T ce ll-recogni t ion of a n t igen by 
nD N A:an t i-nDN A co mplexes or to unava ilability of 
a n t igen du e to antibody binding in the skin . P er-
ha ps in t his way subepiderm a l immunoglobulin in 
clini ca lly norma l skin plays a protective role whi ch 
would ex pl a in its infrequen t coex is tence wi t h 
chroni c scarrin g s kin lesions. 
'iI Prystwosky SD, Gilli am I N: (Submi tted for publi ca-
tion) 
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